Carcinoma, Hepatocellular

"Carcinoma, Hepatocellular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Descriptor ID	D006528
MeSH Number(s)	C04.557.470.200.025.255 C04.588.274.623.160 C06.301.623.160 C06.552.697.160
Concept/Terms	Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinomas, Hepatocellular Hepatocellular Carcinomas Liver Cell Carcinoma, Adult Liver Cancer, Adult Adult Liver Cancer Adult Liver Cancers Cancer, Adult Liver Cancers, Adult Liver Liver Cancers, Adult Liver Cell Carcinoma Carcinoma, Liver Cell Carcinomas, Liver Cell Cell Carcinoma, Liver Cell Carcinomas, Liver Liver Cell Carcinomas Hepatocellular Carcinoma Hepatoma Hepatomas

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Hepatocellular".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]
Carcinoma, Hepatocellular [C04.557.470.200.025.255]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Liver Neoplasms [C04.588.274.623]
Carcinoma, Hepatocellular [C04.588.274.623.160]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Liver Neoplasms [C06.301.623]
Carcinoma, Hepatocellular [C06.301.623.160]
Liver Diseases [C06.552]
Liver Neoplasms [C06.552.697]
Carcinoma, Hepatocellular [C06.552.697.160]

Below are MeSH descriptors whose meaning is related to "Carcinoma, Hepatocellular".

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Hepatocellular".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Hepatocellular" by people in this website by year, and whether "Carcinoma, Hepatocellular" was a major or minor topic of these publications.

Bar chart showing 105 publications over 21 distinct years, with a maximum of 12 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2005	0	1	1
2006	6	1	7
2007	2	1	3
2008	3	0	3
2009	2	1	3
2010	4	0	4
2011	4	0	4
2012	6	2	8
2013	6	0	6
2014	4	0	4
2015	2	0	2
2016	9	0	9
2017	2	2	4
2018	3	0	3
2019	9	3	12
2020	7	1	8
2021	9	1	10
2022	2	0	2
2023	9	1	10
2024	1	0	1

Below are the most recent publications written about "Carcinoma, Hepatocellular" by people in Profiles.

Achimba F, Faezov B, Cohen B, Dunbrack R, Holford M. Targeting Dysregulated Ion Channels in Liver Tumors with Venom Peptides. Mol Cancer Ther. 2024 Feb 01; 23(2):139-147.

View in: PubMed
Kanwal F, Nelson R, Liu Y, Kramer JR, Hernaez R, Cholankeril G, Rana A, Flores A, Smith D, Cao Y, Beech B, Asch SM. Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.

View in: PubMed
Niture S, Gadi S, Qi Q, Rios-Colon L, Khatiwada S, Fernando RA, Levine KE, Kumar D. Cyanotoxins Increase Cytotoxicity and Promote Nonalcoholic Fatty Liver Disease Progression by Enhancing Cell Steatosis. Toxins (Basel). 2023 06 25; 15(7).

View in: PubMed
Yamada K, Hannya Y, Oikawa T, Yoshida A, Katagiri K, Yoshida S, Koizumi R, Tago N, Shimoyama Y, Kawamura A, Mochimaru Y, Eto K, Yoshida K. Extended-Synaptotagmin 1 Enhances Liver Cancer Progression Mediated by the Unconventional Secretion of Cytosolic Proteins. Molecules. 2023 May 11; 28(10).

View in: PubMed
Wong LL, Landsittel DP, Kwee SA. Liver Transplantation vs Partial Hepatectomy for Stage T2 Multifocal Hepatocellular Carcinoma <3?cm Without Vascular Invasion: A Propensity Score-Matched Survival Analysis. J Am Coll Surg. 2023 09 01; 237(3):568-577.

View in: PubMed
Jacobson JM, Zahrieh D, Strand CA, Cruz-Correa M, Pungpapong S, Roberts LR, Mandrekar SJ, Rodriguez LM, Boyer J, Marrero I, Kraynyak KA, Morrow MP, Sylvester AJ, Pawlicki JM, Gillespie E, Barranco E, Richmond E, Umar A, Weiner DB, Limburg PJ. Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer Prev Res (Phila). 2023 03 01; 16(3):163-173.

View in: PubMed
Hernandez BY, Zhu X, Nagata M, Loo L, Chan O, Wong LL. Cyanotoxin exposure and hepatocellular carcinoma. Toxicology. 2023 03 15; 487:153470.

View in: PubMed
Sun N, Zhang C, Lee YT, Tran BV, Wang J, Kim H, Lee J, Zhang RY, Wang JJ, Hu J, Zhang Z, Alsudaney MS, Hou KC, Tang H, Zhang TX, Liang IY, Zhou Z, Chen M, Yeh AH, Li W, Zhou XJ, Chang HR, Han SB, Sadeghi S, Finn RS, Saab S, Busuttil RW, Noureddin M, Ayoub WS, Kuo A, Sundaram V, Al-Ghaieb B, Palomique J, Kosari K, Kim IK, Todo T, Nissen NN, Tomasi ML, You S, Posadas EM, Wu JX, Wadehra M, Sim MS, Li Y, Wang HL, French SW, Lu SC, Wu L, Pei R, Liang L, Yang JD, Agopian VG, Tseng HR, Zhu Y. HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma. Hepatology. 2023 03 01; 77(3):774-788.

View in: PubMed
Qiu C, Ma Y, Wang B, Zhang X, Wang X, Zhang JY. Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans. Int J Mol Sci. 2023 Feb 13; 24(4).

View in: PubMed
Ma GX, Zhu L, Tan Y, Zhai S, Ma X, Ogunwobi OO, Yang WJ, Ting T, Kim S, Wang MQ. A Comparative Trial of Improving Care for Underserved Asian Americans Infected with Hepatitis B Virus. Dig Dis Sci. 2023 06; 68(6):2333-2343.

View in: PubMed

People

Explore

Similar Concepts

Top Journals